Compare2 funds · 1 pair
Picked · 2YTD
IBBvsFTXHVersus · 5Y · 36.1% held in common1–4measures won
Close to theseFee · YTD
Best of the twoNov 6
  • Lowest cost$ a year on $10kIBB 0.44%
  • Most incometrailing 12-month yieldFTXH 0.67%
  • Best 5 yearsper yearFTXH +12.1%
  • Smallest drop · 1Yworst fall in the past yearFTXH −7.5%
Measures won1–4FTXH wins · of 6 · 5Y
$10,000 · 5Y$17,719FTXH · IBB $13,555
Lowest cost0.44%IBB · $44 on $10k
Most income0.67%FTXH · $67 on $10k
Smallest drop−7.5%FTXH · worst fall in 1Y
Held in common36.1%IBB and FTXH

IBB vs FTXH

5Y
IBB
FTXH
iShares Biotechnology ETF · $11.1BFirst Trust Nasdaq Pharmaceuticals ETF · $1.2B
+23.2%3 years · per year$18,677 · $18,720+23.2%
+6.3%5 years · per year$13,555 · $17,719+12.1%
0.44%Expense ratio$44 · $60 on $10k · lower wins0.60%
0.16%12-mo yield$16 · $67 on $10k0.67%
−9.6%Worst dropSmaller wins−7.5%
23.4%VolatilityLower wins18.3%
1–4FTXH wins
$10,000 · 5 yearsOne scale
$10k startFTXH $17.7kIBB $13.6kOct 2021Nov 2026
Shared top holdingsIBB · FTXH
9.1%GILD3.9%
6.3%REGN3.9%
8.5%AMGN3.7%
7.9%VRTX3.4%
Held in common36.1%
End-of-day Nov 6, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two
@TheETFTracker·theetftracker.com

Both

5Y2 funds
#Trend
1BFTXHFirst Trust Nasdaq Pharmaceuticals ETFReadDesk0.60%0.67%+0.7%+32.4%+45.1%+23.2%+12.1%−7.5%$1.2B
2AIBBiShares Biotechnology ETFReadDesk0.44%0.16%+1.7%+26.7%+35.2%+23.2%+6.3%−9.6%$11.1B
End-of-day Nov 6, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
@TheETFTracker·theetftracker.com

Cards for this view

IBB vs FTXH

5Y
iShares Biotechnology
$13,555
First Trust Nasdaq Pharmaceuticals
$17,719
$10k$15kNov 2021Nov 2026$13,555$17,719$10k$15kNov 2021Nov 2026$13,555$17,719
MeasureIBBFTXH
Fee0.44%0.60%
Cost on $10k a year$44$60
Yield0.16%0.67%
5 years, per year+6.3%+12.1%
3 years, per year+23.2%+23.2%
Worst drop · 1Y−9.6%−7.5%
Volatility · 1Y23.4%18.3%
4–1measures won
FTXH first
36.1%
holdings shared
Nov 6, 2026 · $10,000 five years ago, dividends reinvested
@TheETFTracker·theetftracker.com

SCHD vs VIG

YTD
SchwabSCHD
+31.4%
VIGVanguard
+12.1%
Jan 1Nov 6+31.4%+12.1%
+31.4%Year to date+12.1%
3.0%Yield1.5%
$120BAssets$109B
2–0SCHD wins
End-of-day Nov 6, 2026
@TheETFTracker·theetftracker.com

JEPQ vs JEPI

YTD
J.P. MorganJEPQ
+3.2%
JEPIJ.P. Morgan
+5.3%
Jan 1Nov 6+3.2%+5.3%
+3.2%Year to date+5.3%
12.8%Yield8.1%
$42.6BAssets$46.8B
1–1level
End-of-day Nov 6, 2026
@TheETFTracker·theetftracker.com

SPYM vs SPY

YTD
SPDRSPYM
+8.8%
SPYSPDR
+8.7%
Jan 1Nov 6+8.8%+8.7%
+8.8%Year to date+8.7%
1.1%Yield1.0%
$182BAssets$819B
2–0SPYM wins
End-of-day Nov 6, 2026
@TheETFTracker·theetftracker.com

Overlap: IBB, FTXH

Today
36.1%most shared, IBB and FTXH
IBBFTXH
IBB—36.1%
FTXH36.1%—
End-of-day Nov 6, 2026 · share held in common · outlined: the pair in versus
@TheETFTracker·theetftracker.com

Income After Fees on $10,000

1Y
$7most kept, FTXH
FTXH$67 − $60 = $7
IBB$16 − $44 = −$28
KeptFee
End-of-day Nov 6, 2026 · yield in dollars minus the fee
@TheETFTracker·theetftracker.com